Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1726270 | 0.96 | MEN1 (0.56) | MEN1KMT2AL3MBTL1PKMSRC | |
| SCHEMBL7772930 | 0.90 | CA1 (0.51) | MEN1KMT2A | |
| SCHEMBL11889545 | 0.90 | CYP3A4 (0.52) | MEN1KMT2A | |
| SCHEMBL10782981 | 0.90 | MEN1 (0.50) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL124571 | 0.89 | CYP3A4 (0.55) | — | |
| SCHEMBL27521043 | 0.88 | CYP3A4 (0.56) | MEN1KMT2A | |
| SCHEMBL2639353 | 0.87 | MEN1 (0.45) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL19904731 | 0.87 | MEN1 (0.45) | MEN1KMT2AL3MBTL1PKMALDH1A1 | |
| SCHEMBL3813877 | 0.87 | LTA4H (0.50) | — | |
| Triphenyl Phosphate SCHEMBL7526391 | 0.87 | CYP3A4 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | claimed |
| WO-2024020507-A2 | ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF | JAL THERAPEUTICS, LLC (US) | 2024-01-25 | — | — | WO | claimed |
| US-20130032375-A1 | BROMINATED EPOXY FLAME RETARDANT PLASTICIZER | ICL-IP AMERICA INC. (US) | 2013-02-07 | — | — | US | claimed |
| EP-1973965-B1 | NON-HALOGEN FLAME RETARDANT ADDITIVES FOR USE IN RIGID POLYURETHANE FOAM | SUPRESTA LLC (US) | 2009-08-26 | — | — | EP | claimed |
| US-20090156704-A1 | Non-Halogen Flame Retardant Additives for Use in Rigid Polyurethane Foam | ICL-IP AMERICA INC. | 2009-06-18 | — | — | US | claimed |
| JP-2009522432-A | — | — | 2009-06-11 | — | — | JP | claimed |
| EP-1973965-A1 | NON-HALOGEN FLAME RETARDANT ADDITIVES FOR USE IN RIGID POLYURETHANE FOAM | Supresta LLC (US) | 2008-10-01 | — | — | EP | claimed |
| WO-2007081903-A1 | NON-HALOGEN FLAME RETARDANT ADDITIVES FOR USE IN RIGID POLYURETHANE FOAM | SUPRESTA LLC (US) | 2007-07-19 | — | — | WO | claimed |
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | disclosed |
| CN-118271587-A | Polycarbonate copolymer and preparation method and application thereof | 华东理工大学 | 2024-07-02 | — | — | CN | disclosed |
| CN-118126304-A | Polycarbonate copolymer and preparation method and application thereof | 华东理工大学 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024020507-A2 | ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF | JAL THERAPEUTICS, LLC (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-4277731-A1 | MEMBRANE FOR WATER FILTRATION | Aquaporin A/S (DK) | 2023-11-22 | — | — | EP | disclosed |
| CN-116745025-A | membrane for water filtration | 水通道蛋白有限公司 | 2023-09-12 | — | — | CN | disclosed |
| EP-0823472-A1 | Viscosity index improving additives for phosphate ester-containing hydraulic fluids | ROHM AND HAAS COMPANY (US) | 1998-02-11 | — | — | EP | disclosed |
| CN-1029962-C | Triazole derivatives, their preparation and their use as fungicides | SANKYO CO (JP) | 1995-10-11 | — | — | CN | disclosed |
| CN-1069850-A | Solid composition of agricultural chemical and method for preparing the same | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1993-03-17 | — | — | CN | disclosed |
| CN-1036759-A | Triazole derivative, its preparation method and its purposes as mycocide | SANKYO CO (JP) | 1989-11-01 | — | — | CN | disclosed |
| CN-85101429-B | Microcapsules and process for making microcapsules | 斯多佛化学有限公司 | 1988-08-17 | — | — | CN | disclosed |
| CN-85101429-A | The process of microencapsulation and preparing microcapsules | — | 1987-01-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | ACHE, BCHE, MUSK | MEN1 4330/4885KMT2A 3792/4885L3MBTL1 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.